A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
מצבים רפואיים
Hypertrophic Cardiomyopathy
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Local Institution - 0008, Beijing, Beijing Municipality, China
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Zhuang Tian)Peking University First Affiliated Hospital, Beijing, Beijing Municipality, China
Local Institution - 0009, Guangzhou, Guangdong, China
The Second Afilliated Hospital of Hebei Medical University, Jiazhuang, Hebei, China
Local Institution - 0003, Harbin, Heilongjiang, China
Local Institution - 0007, Zhengzhou, Henan, China
Suzhou Municipal Hospital, Suzhou, Jiangsu, China
The Second Hospital of Jilin University, Changchun, Jilin, China
Local Institution - 0005, Dalian, Liaoning, China
Local Institution - 0013, Xi'an, Shan3xi, China
West China Hospital of Sichuan University, Chengdu, Sichuan, China
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Xiaojie Xie)Local Institution - 0010, Jinan, China
Zhongshan Hospital Fudan University, Shanghai, China
מובילי המחקר
Bristol Myers Squibb
Study Director
Bristol-Myers Squibb